Cargando…

Prostate cancer epidemiology and prognostic factors in the United States

OBJECTIVE: Using the latest cohort study of prostate cancer patients, explore the epidemiological trend and prognostic factors, and develop a new nomogram to predict the specific survival rate of prostate cancer patients. METHODS: Patients with prostate cancer diagnosed from January 1, 1975 to Decem...

Descripción completa

Detalles Bibliográficos
Autores principales:	Abudoubari, Saimaitikari, Bu, Ke, Mei, Yujie, Maimaitiyiming, Abudukeyoumu, An, Hengqing, Tao, Ning
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10603232/ https://www.ncbi.nlm.nih.gov/pubmed/37901326 http://dx.doi.org/10.3389/fonc.2023.1142976

Ejemplares similares

Preliminary study on miRNA in prostate cancer
por: Abudoubari, Saimaitikari, et al.
Publicado: (2023)

Effect of interaction between occupational stress and polymorphisms of MTHFR gene and SELE gene on hypertension
por: Yang, Fen, et al.
Publicado: (2022)

Metabolic syndrome and metastatic prostate cancer correlation study, a real-world study in a prostate cancer clinical research center, Xinjiang, China
por: An, Hengqing, et al.
Publicado: (2022)

A retrospective study: analysis of the relationship between lactate dehydrogenase and castration-resistant prostate cancer based on restricted cubic spline model
por: Qiu, Ruiying, et al.
Publicado: (2023)

Malignant Pleural Mesothelioma Epidemiology in the United States From 2000 to 2016
por: Thomas, Akesh, et al.
Publicado: (2021)

Causes of Death Among Prostate Cancer Patients Aged 40 Years and Older in the United States
por: Ye, Yuzhong, et al.
Publicado: (2022)

Prostate cancer recurrence – new prognostic factors are needed
por: Wajsman, Zew
Publicado: (2013)

Subtype and prognostic analysis of immunogenic cell death-related gene signature in prostate cancer
por: Kang, Zhen, et al.
Publicado: (2023)

Epidemiologic Characteristics, Prognostic Factors, and Treatment Outcomes in Primary Central Nervous System Lymphoma: A SEER-Based Study
por: Tang, Dongsheng, et al.
Publicado: (2022)

Factors That Determine Multiple Primary Cancers in the Adult Population in the United States
por: Okeke, Francis, et al.
Publicado: (2023)

β-catenin as a prognostic factor for prostate cancer (PCa)
por: Nowicki, Andrzej, et al.
Publicado: (2012)

Computer classification and construction of a novel prognostic signature based on moonlighting genes in prostate cancer
por: Mei, Wangli, et al.
Publicado: (2022)

Epithelial Splicing Regulatory Protein (ESPR1) Expression in an Unfavorable Prognostic Factor in Prostate Cancer Patients
por: Lee, Hyung Ho, et al.
Publicado: (2020)

Prognostic factors and treatment outcomes of spinal osteosarcoma: Surveillance, epidemiology, and end results database analysis
por: Wang, Jing, et al.
Publicado: (2023)

Cohort profile: the Turin prostate cancer prognostication (TPCP) cohort
por: Destefanis, Nicolas, et al.
Publicado: (2023)

The epidemiological patterns of non-Hodgkin lymphoma: global estimates of disease burden, risk factors, and temporal trends
por: Chu, Yurou, et al.
Publicado: (2023)

State-Level Disparity in Lung Cancer Survival in the United States
por: Lee, Yu-Che, et al.
Publicado: (2020)

Identification of a prognostic biomarker predicting biochemical recurrence and construction of a novel nomogram for prostate cancer
por: Yu, Zhaojun, et al.
Publicado: (2023)

Trends in Breast Cancer Incidence and Mortality in the United States From 2004-2018: A Surveillance, Epidemiology, and End Results (SEER)-Based Study
por: Bazzi, Talal, et al.
Publicado: (2023)

Development and validation of a predictive model for diagnosing prostate cancer after transperineal prostate biopsy
por: Ren, Wenming, et al.
Publicado: (2022)

MAFG-AS1 is a prognostic biomarker and facilitates prostate cancer progression
por: Li, Peizhang, et al.
Publicado: (2022)

Prognostic significance of lncRNA AP004608.1 in prostate cancer
por: Li, Wei, et al.
Publicado: (2022)

Glucose transporters: Important regulators of endometrial cancer therapy sensitivity
por: Zhang, Xing, et al.
Publicado: (2022)

Analysis of the regulatory mechanisms of prognostic immune factors in thyroid cancer
por: Tian, Yin, et al.
Publicado: (2022)

Risks of prostate cancer and mortality in the city of Sharjah, United Arab Emirates
por: Al Shareef, Zainab, et al.
Publicado: (2023)

Epidemiological Determinants of Advanced Prostate Cancer in Elderly Men in the United States
por: Jayasekera, Jinani, et al.
Publicado: (2019)

Epidemiology and risk stratification of low-grade gliomas in the United States, 2004-2019: A competing-risk regression model for survival analysis
por: Cao, Junguo, et al.
Publicado: (2023)

Early Mortality of Prostatectomy vs. Radiotherapy as a Primary Treatment for Prostate Cancer: A Population-Based Study From the United States and East Germany
por: Medenwald, Daniel, et al.
Publicado: (2020)

Multi-omics analysis of expression and prognostic value of NSUN members in prostate cancer
por: Sun, Guangyu, et al.
Publicado: (2022)

Availability and Affordability of Oncology Drugs in 2012-2021 in China and the United States
por: Huang, Huiyao, et al.
Publicado: (2022)

Incidence, Prognostic Factors and Survival for Hemangioblastoma of the Central Nervous System: Analysis Based on the Surveillance, Epidemiology, and End Results Database
por: Yin, Xiangdong, et al.
Publicado: (2020)

The Epidemiological Characteristics and Prognostic Factors of Low-Grade Brainstem Glioma: A Real-World Study of Pediatric and Adult Patients
por: Liu, Zhuoyi, et al.
Publicado: (2020)

Prognostic factors for multi-organ dysfunction in pediatric oncology patients admitted to the pediatric intensive care unit
por: Soeteman, Marijn, et al.
Publicado: (2023)

Prognostic Value of Genes and Immune Infiltration in Prostate Tumor Microenvironment
por: Sun, Wenguo, et al.
Publicado: (2020)

Corrigendum: Early Mortality of Prostatectomy vs. Radiotherapy as a Primary Treatment for Prostate Cancer: A Population-Based Study From the United States and East Germany
por: Medenwald, Daniel, et al.
Publicado: (2021)

Trends in Incidence, Mortality, and Survival of Penile Cancer in the United States: A Population-Based Study
por: Deng, Xinxi, et al.
Publicado: (2022)

LPAR1, Correlated With Immune Infiltrates, Is a Potential Prognostic Biomarker in Prostate Cancer
por: Shi, Jingqi, et al.
Publicado: (2020)

Identification of Metabolism-Associated Prostate Cancer Subtypes and Construction of a Prognostic Risk Model
por: Zhang, Yanlong, et al.
Publicado: (2020)

Development and Verification of a Prostate Cancer Prognostic Signature Based on an Immunogenomic Landscape Analysis
por: Cheng, Hong, et al.
Publicado: (2021)

Identification and Validation of a Prognostic Signature for Prostate Cancer Based on Ferroptosis-Related Genes
por: Liu, Huan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_6nq7g4dm3i1hfd7p8f9l0jgrhr